US equities |
NVDA $221.30 ▼-3.16% MU $914.13 ▼-4.10% AAPL $342.96 ▲+0.50% AMD $570.82 ▼-5.73% META $737.54 ▼-3.27% MSFT $533.69 ▼-1.80% TSLA $367.16 ▼-2.15% SPCX $152.16 ▼-2.80%
FinancialContent

IRIDEX Corporation - Common Stock (NQ:IRIX)

0.8241 -0.0242 (-2.85%)
Delayed Quote Updated: 4:00 PM EDT, Oct 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IRIDEX Corporation - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Iridex Announces the Publication of Two-Year Independent Study Supporting Benefits of MicroPulse® Technology for Early to Advanced Glaucoma
Study reports sustained IOP reduction and reduced medication burden over 24 months 
From IRIDEX Corporation
Via GlobeNewswire
What's going on in today's after hours session ↗
Via Chartmill
News headline image
Iridex Completes Relocation of Manufacturing Facility to San Jose, California
Company Expects to Realize Approximately $600,000 in Annualized Cost Savings 
From IRIDEX Corporation
Via GlobeNewswire
News headline image
IRIDEX (IRIX) Q2 2026 Earnings Call Transcript ↗
Glaucoma probe sales surged 35% as retina revenue declined amid international transitions. 
Via The Motley Fool
Topics Earnings
Iridex Corp (NASDAQ:IRIX) Q1 Loss Narrower Than Expected, Glaucoma Portfolio Strengthens ↗
Via Chartmill
IRIDEX Corp (NASDAQ:IRIX) Reports Mixed Q4 Results with Revenue Growth and Narrowed Loss ↗
Via Chartmill
News headline image
Full Transcript: Iridex Q2 2026 Earnings Call ↗
Iridex (NASDAQ:IRIX) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts and... 
Via Benzinga
Topics Earnings
News headline image
Iridex Reports Second Quarter 2026 Financial Results
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex (IRIX) Q1 2026 Earnings Transcript ↗
Iridex (IRIX) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Earnings Economy
News headline image
Iridex Reports First Quarter 2026 Financial Results
2026 Guidance Affirmed 
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex to Report First Quarter 2026 Financial Results on May 19, 2026
From IRIDEX Corporation
Via GlobeNewswire
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
News headline image
Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology
From IRIDEX Corporation
Via GlobeNewswire
News headline image
IRIDEX (IRIX) Q4 2025 Earnings Call Transcript ↗
IRIDEX (IRIX) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings World Trade
News headline image
Iridex Reports Fourth Quarter and Full Year 2025 Financial Results
Strong Q4 and Full Year 2025 Revenue Performance Underpinned by Continued Operational Efficiencies 
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Announces Plans to Relocate Headquarters
Move expected to generate significant cost savings 
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025
Demonstrating continued revenue growth, operational efficiencies and positive cash flow 
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse® Technology in Glaucoma Management
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Technology and Continuous-Wave Laser for Glaucoma Treatment
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex to Present at the Sidoti Year-End Virtual Investor Conference
From IRIDEX Corporation
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why LightPath Technologies Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Iridex Corp (NASDAQ:IRIX) Reports Mixed Q3 2025 Results, Stock Falls Over 13% on Earnings Miss ↗
Iridex (IRIX) reported mixed Q3 2025 results, missing revenue and EPS estimates. The stock fell over 13% despite highlighting operational improvements and cost reductions. 
Via Chartmill
News headline image
Iridex Reports Third Quarter 2025 Financial Results
From IRIDEX Corporation
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >